Evidence map›Paper›PMID 37886644›Full record

ReviewFrontiers in endocrinology2023

Sandra Pihlström, Sampo Richardt, Kirsi Määttä, Minna Pekkinen, Vesa M Olkkonen, Outi Mäkitie, Riikka E Mäkitie

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. PathogenicFrontiers in endocrinology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Human genetic defects of sphingolipid synthesis.Journal of inherited metabolic disease · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Sandra PihlströmFolkhälsan Institute of Genetics, Helsinki, Finland.
Sampo RichardtFolkhälsan Institute of Genetics, Helsinki, Finland.
Kirsi MäättäFolkhälsan Institute of Genetics, Helsinki, Finland.
Minna PekkinenFolkhälsan Institute of Genetics, Helsinki, Finland.
Vesa M OlkkonenMinerva Foundation Institute for Medical Research, Helsinki, Finland.
Outi MäkitieFolkhälsan Institute of Genetics, Helsinki, Finland.
Riikka E MäkitieFolkhälsan Institute of Genetics, Helsinki, Finland.
Folkhälsans Forskningscentrum · FIKarolinska Institutet · SEMinerva Foundation · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogenic heterozygous variants in

Indexed as

Facial NerveOsteoporosisTransferases (Other Substituted Phosphate Groups)AnimalsChildHumansInfant, NewbornParalysisSkullSphingomyelinsSGMS2 protein, humanSphingomyelinsTransferases (Other Substituted Phosphate Groups)bone and neural tissueSGMS2-related osteoporosisSMS2sphingolipidssphingomyelin metabolism

Identifiers

PMID37886644
PMCPMC10598846
OpenAlexW4387538364

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.